Protocoles en coursCohorte nationale de patients emphysémateux déficitaires en alpha-1 antitrypsine: Rationnel et mise en placeNational cohort of patients with emphysema and alpha-1 antitrypsin deficiency
Références (9)
- et al.
The direct medical costs of alpha(1)-antitrypsin deficiency
Chest
(2001) - et al.
Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals
J Clin Invest
(1986) Alpha1-antitrypsin deficiency (first of two parts)
N Engl J Med
(1978)Alpha1-antitrypsin deficiency (second of two parts)
N Engl J Med
(1978)
There are more references available in the full text version of this article.
Cited by (8)
French clinical practice guidelines for the diagnosis and management of lung disease with alpha 1-antitrypsin deficiency
2022, Revue des Maladies RespiratoiresDiagnosis of alpha-1 antitrypsin deficiency: Modalities, indications and diagnosis strategy
2014, Revue des Maladies RespiratoiresCitation Excerpt :α1-AT deficiency is one of the most common hereditary diseases with a frequency as high as that of cystic fibrosis [3]. However, the diagnosis is often delayed [4–6]. α1-AT belongs to the serine protease inhibitor serpin superfamily, which plays a major role in the regulation of physiological processes such as inflammation and coagulation [7].
Augmentation therapy with alpha-1 antitrypsin: 20 Year- follow-up of a deficient patient
2008, Revue des Maladies RespiratoiresCharacteristics of the patients included in the French cohort of patients with emphysema caused by alpha-1 antitrypsin deficiency
2008, Revue des Maladies RespiratoiresAlpha-1 antitrypsin deficiency
2007, Revue des Maladies RespiratoiresThe Journal of Respiratory Diseases: A «new» journal? Description and instructions
2005, Revue des Maladies Respiratoires
- 1
au nom du Conseil Scientifique.
Copyright © 2005 SPLF. Published by Elsevier Masson SAS All rights reserved.